KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Moderna (MRNA) over the last 7 years, with Dec 2024 value amounting to $384.8 million.

  • Moderna's Shares Outstanding (Weighted Average) rose 1.22% to $389.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.1 million, marking a year-over-year increase of 1.22%. This contributed to the annual value of $384.8 million for FY2024, which is 0.93% up from last year.
  • According to the latest figures from FY2024, Moderna's Shares Outstanding (Weighted Average) is $384.8 million, which was up 0.93% from $381.3 million recorded in FY2023.
  • In the past 5 years, Moderna's Shares Outstanding (Weighted Average) registered a high of $405.4 million during FY2021, and its lowest value of $381.3 million during FY2023.
  • For the 3-year period, Moderna's Shares Outstanding (Weighted Average) averaged around $383.4 million, with its median value being $384.2 million (2022).
  • Per our database at Business Quant, Moderna's Shares Outstanding (Weighted Average) grew by 18.74% in 2020 and then dropped by 5.25% in 2022.
  • Moderna's Shares Outstanding (Weighted Average) (Yearly) stood at $395.7 million in 2020, then increased by 2.46% to $405.4 million in 2021, then decreased by 5.25% to $384.2 million in 2022, then declined by 0.75% to $381.3 million in 2023, then increased by 0.93% to $384.8 million in 2024.